RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
September 19, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology...
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York
August 27, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology...
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
August 14, 2024 08:30 ET
|
RenovoRx, Inc.
Phase III clinical trial is evaluating RenovoGem™ for the treatment of Locally Advanced Pancreatic Cancer UNMC opened enrollment of TIGeR-PaC in June 2024 and joins esteemed clinical sites throughout...
RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®
July 31, 2024 08:30 ET
|
RenovoRx, Inc.
Published data shows that chemotherapy delivered via TAMP™ with prior chemoradiation in Locally Advanced Pancreatic Cancer (LAPC) observed an Overall Survival (OS) of 27-months Targeted chemotherapy...
Healthcare Technology Management Market Size to Hit US$ 26.04 Billion By 2032, Increasing Prevalence of Chronic Diseases & Aging Global Population Drives Growth | SNS Insider
July 16, 2024 13:38 ET
|
SNS Insider pvt ltd
Pune, July 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Technology Management Market Size & Growth: “According to SNS Insider Research, The Healthcare Technology Management Market size was valued...
RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®
July 08, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology...
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
June 26, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology...
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
June 10, 2024 08:30 ET
|
RenovoRx, Inc.
LOS ALTOS, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology...
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
January 31, 2024 09:00 ET
|
NeurAxis, Inc.
CARMEL, Ind., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company commercializing neuromodulation therapies that...
Global Healthcare Technology Management Market Size To Worth USD 20.78 Billion By 2032 | CAGR of 12.5%
November 30, 2023 06:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Nov. 30, 2023 (GLOBE NEWSWIRE) -- The Global Healthcare Technology Management Market size is to grow from USD 6.40 Billion in 2022 to USD 20.78 Billion by 2032, at a...